» Articles » PMID: 8759265

Indocyanine Green Angiographic Findings in Serpiginous Choroidopathy

Overview
Journal Br J Ophthalmol
Specialty Ophthalmology
Date 1996 Jun 1
PMID 8759265
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Analysis of the choroidal findings in patients affected by serpiginous choroidopathy (SC).

Methods: Thirteen patients (23 eyes; 11 males and two females; age range 50-68 years; mean age 59.1 years) affected by SC were examined with fluorescein angiography (FA) and indocyanine green angiography (ICGA). The follow up period was 7-33 months.

Results: Using ICGA the disease could be divided into the following stages: (1) subclinical or choroidal stage (hypofluorescent lesions without FA evidence); (2) active stage (with ICGA and FA evidence); (3) subhealing stage (slight late hyperfluorescent lesions with ICGA, with no evidence on FA); (4) inactive or healed stage (hypofluorescent areas with ICGA and hyperfluorescent areas with FA).

Conclusions: Although FA showed a clear distinction between active and healed stages, ICGA allowed a greater subdivision of the disease. In particular, ICGA allowed: (1) better staging of SC, revealing choroidal alterations when there was no ophthalmoscopic or FA evidence; (2) better identification of the active lesions which appear to be larger at the choroidal level in comparison with the corresponding retinal lesions; and (3) revealed a persistence of choroidal activity even when the signs of retinal activity had disappeared. Thus, ICGA should be a particularly useful clinical and therapeutic monitoring tool of SC.

Citing Articles

Choroidal vasculitis as a biomarker of inflammation of the choroid. Indocyanine Green Angiography (ICGA) spearheading for diagnosis and follow-up, an imaging tutorial.

Papasavvas I, Tucker W, Mantovani A, Fabozzi L, Herbort Jr C J Ophthalmic Inflamm Infect. 2024; 14(1):63.

PMID: 39633039 PMC: 11618284. DOI: 10.1186/s12348-024-00442-w.


Tubercular serpiginous choroiditis.

Bansal R, Gupta V J Ophthalmic Inflamm Infect. 2022; 12(1):37.

PMID: 36352169 PMC: 9645760. DOI: 10.1186/s12348-022-00312-3.


Multimodal imaging supporting the pathophysiology of white dot syndromes.

Testi I, Modugno R, Pavesio C J Ophthalmic Inflamm Infect. 2021; 11(1):32.

PMID: 34529201 PMC: 8446150. DOI: 10.1186/s12348-021-00261-3.


Optical coherence tomography angiography (OCTA) findings in Serpiginous Choroiditis.

Macedo S, Pohlmann D, Lenglinger M, Pleyer U, Joussen A, Winterhalter S BMC Ophthalmol. 2020; 20(1):258.

PMID: 32605555 PMC: 7325353. DOI: 10.1186/s12886-020-01527-5.


Enigma of serpiginous choroiditis.

Dutta Majumder P, Biswas J, Gupta A Indian J Ophthalmol. 2019; 67(3):325-333.

PMID: 30777946 PMC: 6407399. DOI: 10.4103/ijo.IJO_822_18.


References
1.
Laatikainen L, ERKKILA H . Serpiginous choroiditis. Br J Ophthalmol. 1974; 58(9):777-83. PMC: 1215025. DOI: 10.1136/bjo.58.9.777. View

2.
Hamilton A, Bird A . Geographical choroidopathy. Br J Ophthalmol. 1974; 58(9):784-97. PMC: 1215026. DOI: 10.1136/bjo.58.9.784. View

3.
Chisholm I, GASS J, Hutton W . The late stage of serpiginous (geographic) choroiditis. Am J Ophthalmol. 1976; 82(3):343-51. DOI: 10.1016/0002-9394(76)90482-7. View

4.
De Laey J . Fluoro-angiographic study of the choroid in man. Bull Soc Belge Ophtalmol. 1977; 174:III-VII, 1-217. View

5.
Weiss H, Annesley Jr W, Shields J, Tomer T, Christopherson K . The clinical course of serpiginous choroidopathy. Am J Ophthalmol. 1979; 87(2):133-42. DOI: 10.1016/0002-9394(79)90131-4. View